CD109 and triple-negative breast carcinoma: Recent studies have also revealed that CD109-positive cells isolated by flow cytometry had higher sphere-forming ability and maintained the similar features of cancer-initiating cell population in epithelioid sarcoma.25 Tao et al.24 also pointed out that CD109 + CSCs have stronger tumorigenicity, both in vitro and in vivo in triple-negative breast cancer.